John A. McLane
8Patents
3h-index
10Co-inventors
46Inventor score
Filing activity: Nov 14, 1988 → Nov 23, 1994
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5021451A | Method for inhibiting hyperproliferative diseases | Human Necessities | 78 | Expired |
| US5428029A | Vitamin D3 fluorinated analogs | Emerging Cross-Sectional Technologies | 39 | Expired |
| US5401733A | Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol | Human Necessities | 5 | Expired |
| US5342833A | Vitamin D3 analogs | Chemistry; Metallurgy | 3 | Expired |
| US5393900A | Steroid intermediates for the formation of vitamin D.sub.3 analogues | Chemistry; Metallurgy | 2 | Expired |
| US5073568A | Antipsoriatic agents | Chemistry; Metallurgy | 1 | Expired |
| US5747478A | Vitamin D3 analogs for the treatment of psoriasis and sebaceous gland diseases | Chemistry; Metallurgy | 1 | Expired |
| US5200549A | Antipsoriatic agents | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.